Exact Mass: 460.08596460000007
Exact Mass Matches: 460.08596460000007
Found 236 metabolites which its exact mass value is equals to given mass value 460.08596460000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flupoxam
Pre- and post emergence herbicide for broad-leaved weed control in winter cereals. Pre- and post emergence herbicide for broad-leaved weed control in winter cereals
Apremilast, (+/-)-
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
Irilone 4'-glucoside
Irilone 4-glucoside is found in herbs and spices. Irilone 4-glucoside is isolated from the roots of Trifolium pratense (red clover). Isolated from the roots of Trifolium pratense (red clover). Irilone 4-glucoside is found in tea and herbs and spices.
3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl]oxy}oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(6-hydroxy-7-methoxy-4-oxo-2-phenyl-4H-chromen-5-yl)oxy]oxane-2-carboxylic acid
Glycitein 4'-O-glucuronide
Glycitein 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Glycitein 7-O-glucuronide
Glycitein 7-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
N-Desmethyl vandetanib
C21H22BrFN4O2 (460.09100639999997)
N-Desmethyl vandetanib is a metabolite of vandetanib. Vandetanib (rINN, trade name Caprelsa), also known as ZD6474, is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR). It is a tyrosine kinase inhibitor, being developed by AstraZeneca. It has a third target: inhibiting RET-tyrosine kinase activity, an important growth driver in certain types of thyroid cancer (Wikipedia)
Biochanin a 7-glucuronide
Oroxylin A glucoronide
5-Carboxyfluorescein diacetate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
6-Carboxyfluorescein diacetate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
Apremilast
Ponesimod
C23H25ClN2O4S (460.12234800000004)
3',6'-Diacetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-4-carboxylic acid
Tecarfarin
C21H14F6O5 (460.07453860000004)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
Wogonoside
ParishinE
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
oroxyloside
Oroxylin A 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A. It has a role as a plant metabolite. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to an oroxylin A. It is a conjugate acid of an oroxylin A 7-O-beta-D-glucuronate. Oroxylin A glucoronide is a natural product found in Scutellaria racemosa, Scutellaria squarrosa, and other organisms with data available. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
Baicalin methyl ester
Baicalin methyl ester is a constituent of the roots of S. baicalmsis[1].
Oroxylin
Oroxylin A 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A. It has a role as a plant metabolite. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to an oroxylin A. It is a conjugate acid of an oroxylin A 7-O-beta-D-glucuronate. Oroxylin A glucoronide is a natural product found in Scutellaria racemosa, Scutellaria squarrosa, and other organisms with data available. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
Oroxindin
Wogonin 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of wogonin. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to a wogonin. It is a conjugate acid of a wogonin 7-O-beta-D-glucuronate. Oroxindin is a natural product found in Scutellaria discolor, Scutellaria indica, and other organisms with data available. See also: Glycyrrhiza Glabra (part of). The glycosyloxyflavone which is the 7-O-glucuronide of wogonin. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2]. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2].
Baicalin
Baicalin methyl ester is a constituent of the roots of S. baicalmsis[1].
Parishin
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
Wogonoside
Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2]. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2].
Apigenin 7-O-beta-D-glucuronopyranoside methyl ester
oroxylin A-7-O-glucuronide
Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
(R)-4,4-dihydroxy-3-(4-dihydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1,(16),3,5,7(19),14,17-hexaene-12,2(5H)-furan}-11,5-dione|(R)-4,4-dihydroxy-3-(4-hydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1(17),3,5,7(19),14(18),15-hexaene-12,2(5H)-furan}-11,5-dione|retipolide E
4,5,7,8-tetrahydroxyflavone 8-O-beta-D-glucopyranosiduronic acid methyl ester
7,3,4-trihydroxy-5-O-beta-D-(2-O-acetyl)xylopyranosyl-isoflavone
3,3-Dimethyl-6-hydroxy-9beta-(1-methylethenyl)-11-methoxy-9a,13a-epoxy-3H,7H-4,14-dioxadibenz[a,j]anthracene-7,10,13-trione
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-6-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
Irilone 4'-glucoside
Glycitein 4'-O-glucuronide
Glycitein 7-O-glucuronide
glutaraldehyde 2,4-dinitrophenylhydrazone
C17H16N8O8 (460.10910559999996)
(5-Methyl-3-phenyl-1,2-oxazol-4-yl){4-[2-nitro-4-(trifluoromethyl )phenyl]-1-piperazinyl}methanone
C22H19F3N4O4 (460.13583300000005)
6-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]tryptoph
C26H21ClN2O4 (460.11897760000005)
Apremilast
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Levocetirizine dihydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].
1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose
Losartan potassium
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents B - Blood and blood forming organs > B03 - Antianemic preparations Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.
3-phenylpropyl triphenylphosphonium bromide
C27H26BrP (460.09553860000005)
4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboxamide
Cetirizine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine dihydrochloride, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine dihydrochloride marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].
Flupoxam
3(or 6)-Carboxy-9,10-dihydro-9,10-dioxo-1-anthracenyl beta-D-glucopyranosiduronic acid
Ponesimod
C23H25ClN2O4S (460.12234800000004)
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent
(9beta,13alpha,14beta,17alpha)-2-Methoxyestra-1,3,5(10)-Triene-3,17-Diyl Disulfamate
1-[(2,6-Difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine
2-((4aR,5R,5aR,8aR,9S)-10-(4-fluorophenyl)-2,6,8-trioxo-2,3,4a,5,5a,6,8a,9,9a,10-decahydro-5,9-methanothiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(8H)-yl)acetic acid
C21H17FN2O5S2 (460.05628839999997)
N-[5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]naphthalene-1-carboxamide
2-(5-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-2-fluoro-6-oxido-1,1-biphenyl-3-YL)succinate
Tecarfarin
C21H14F6O5 (460.07453860000004)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(methylamino)ethyl hydrogen phosphate
C12H22N4O11P2 (460.07602819999994)
gammaGluCys(IAN)Gly(1-)
C20H22N5O6S- (460.12907320000005)
A peptide anion obtained by deprotonation of the carboxy groups and protonation of the free amino group of gammaGluCys(IAN)Glu.
Aspartyl adenylate beta-ketophosphonate isostere
An organic phosphonate that is adenosine having a [(3S)-3-amino-4-carboxy-2-oxobutyl](hydroxy)phosphoryl group attached at position 5.
[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-[3-(hydroxyamino)propyl]phosphinic acid
C12H22N4O11P2 (460.07602819999994)
Glycitein 4-O-glucuronide
A glycosyloxyisoflavone that is the glucuronide-conjugated form of the phytoestrogen glycitein.
(5Z)-5-[[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one
C23H25ClN2O4S (460.12234800000004)
N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide
N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide
N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide
N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide
4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide
C20H17ClN4O3S2 (460.04305619999997)
2-(1-Naphthalenyl)acetic acid [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester
C22H21ClN2O5S (460.08596460000007)
2-[[2-[[4-hydroxy-6-oxo-5-(phenylmethyl)-1H-pyrimidin-2-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester
2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranuronosyloxy)-4-oxo-4H-chromen-5-olate
3-[2-hydroxyethyl-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]sulfamoyl]benzoic acid ethyl ester
N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide
C19H17ClN6O2S2 (460.05428919999997)
2-[4-Hydroxy-6-(toluene-4-sulfonylamino)-pyrimidin-2-ylsulfanyl]-N-(4-methoxy-phenyl)-acetamide
(2R)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C19H29BrN2O4S (460.10312940000006)
4-[3-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropyl]morpholin-3-one
(2S)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C19H29BrN2O4S (460.10312940000006)
(2S)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C19H29BrN2O4S (460.10312940000006)
(2R)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C19H29BrN2O4S (460.10312940000006)
4-[[3-(3-methoxyphenyl)-3-oxopropylidene]amino]-N-quinoxalin-2-ylbenzenesulfonamide
C24H20N4O4S (460.12052000000006)
3,4,5-Trihydroxy-6-(6-hydroxy-5-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
2-Piperidin-1-yl-1-(3,9,11-trichloro-5,6-dihydrobenzo[c]acridin-7-yl)ethanol
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-5-yl]oxyoxane-2-carboxylic acid
(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-8-yl]oxane-2-carboxylic acid
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-(5-hydroxy-7-methoxy-4-oxochromen-3-yl)phenoxy]oxane-2-carboxylic acid
(E)-6,6,6-trichloro-3-methoxy-N,5-dimethyl-N-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] pentanoate
3,8,18,23-Tetrahydroxy-10,16-dimethyl-5,21-dioxaheptacyclo[11.9.1.11,15.14,7.02,12.011,25.019,24]pentacosa-2(12),3,7,9,11(25),15(24),16,18-octaene-6,14,20-trione
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] butanoate
luteolin 7-O-beta-D-glucosiduronate(2-)
A carbohydrate acid derivative anion arising from deprotonation of the carboxy and 5-hydroxy groups of luteolin 7-O-beta-D-glucosiduronic acid; major species at pH 7.3 (according to Marvin v 6.2.0.).
Oroxylin A 7-O-beta-D-glucuronide
The glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A.
Cetirizine Impurity C (dihydrochloride)
Cetirizine Impurity C dihydrochloride is an impurity of Cetirizine. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist[1][2].
Octoclothepin (maleate salt)
C23H25ClN2O4S (460.12234800000004)
Octoclothepin maleate salt, an orally active neuroleptic agent, is a dual SR-2A and D2DR inhibitor. Octoclothepin maleate salt reveals an intensive central depressant action in a series of observational and instrumental procedures in rodents[1][2].
(6ar,9r,9ar)-9-acetyl-5-bromo-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
(1s,2r,4r)-2-bromo-4-[(2e,4e)-5-[(1r,4r)-4-bromo-1,3,3-trimethylcyclohexyl]penta-2,4-dien-2-yl]-1-methylcyclohexan-1-ol
methyl (2s)-3-{[(2s)-3-methoxy-2-[(3r)-3-methyl-2,5-dioxopyrrolidin-1-yl]-3-oxopropyl]disulfanyl}-2-[(3r)-3-methyl-2,5-dioxopyrrolidin-1-yl]propanoate
C18H24N2O8S2 (460.09740239999996)
methyl (1r,2s,4r,5s,7s,9s,12r,14s,15r)-5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylic acid
(4s,8r)-8,16-dihydroxy-2',4'-dioxaspiro[pentacyclo[9.7.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁹]nonadecane-3,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1(18),1'(13'),2(9),5',6,7',9',10,11',12,15(19),16-dodecaene-5,14-dione
[(2s,3r,4r,5s)-5-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate
(4s)-4,7,11,18-tetramethyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
3-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl (2s,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoate
methyl (2s,3s,4s,5r,6s)-6-[(5,7-dihydroxy-4-oxo-2-phenylchromen-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylate
baicalein 6-methylether-7-o-β-galactopyranuro-noside
{"Ingredient_id": "HBIN017510","Ingredient_name": "baicalein 6-methylether-7-o-\u03b2-galactopyranuro-noside","Alias": "NA","Ingredient_formula": "C22H20O11","Ingredient_Smile": "COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)OC4C(C(C(C(O4)C(=O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2105","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(6r)-6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxochromen-7-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid
8,14-dihydroxy-2',4'-dioxaspiro[pentacyclo[9.7.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁹]nonadecane-3,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1,1'(13'),5',6,7',9,9',11,11',13,15(19),17-dodecaene-5,16-dione
(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-[(5-hydroxy-6-methoxy-4-oxo-2-phenylchromen-7-yl)oxy]oxane-2-carboxylic acid
(2s,3r,4s,5r)-2-{[3-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxochromen-5-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[(6-hydroxy-7-methoxy-4-oxo-2-phenylchromen-5-yl)oxy]oxane-2-carboxylic acid
12-chloro-13-hydroxy-5-(2-hydroxy-1-methanesulfinylpropan-2-yl)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(1s,2r,4s,5r,10s,12r,13r,14r,17r)-12-chloro-13-hydroxy-5-[(2r)-2-hydroxy-1-methanesulfinylpropan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
4,7,11,18-tetramethyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
4,4'-dihydroxy-3-(4-hydroxyphenyl)-2',10'-dioxaspiro[furan-2,12'-tricyclo[12.2.2.1³,⁷]nonadecane]-1'(16'),3'(19'),4',6',14',17'-hexaene-5,11'-dione
5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl 2,3,4,5-tetrahydroxy-6-oxohexanoate
(4s,11s,18r)-4,7,11,18-tetramethyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
(2r,3s,4s,5r)-5-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl acetate
methyl (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylate
methyl 3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylate
9-hydroxy-7-(4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2h-[1,3]dioxolo[4,5-g]chromen-8-one
methyl (2s,3s,4r,5r,6s)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3,4,5-trihydroxyoxane-2-carboxylate
(3r,4r,5r,6r)-2,3,4-trihydroperoxy-6-(hydroxymethyl)-5-phenoxy-5-(phenylperoxy)oxane-2,3,4-triol
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[(5-hydroxy-6-methoxy-4-oxo-2-phenylchromen-7-yl)oxy]oxane-2-carboxylic acid
methyl 6-[(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylate
3-(acetyloxy)-5-[2,4,6-tris(acetyloxy)phenoxy]phenyl acetate
methyl 5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate
14-hydroxy-13-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
(1s,13r,23s)-3,8,18,23-tetrahydroxy-10,16-dimethyl-5,21-dioxaheptacyclo[11.9.1.1¹,¹⁵.1⁴,⁷.0²,¹².0¹¹,²⁵.0¹⁹,²⁴]pentacosa-2(12),3,7(25),8,10,15(24),16,18-octaene-6,14,20-trione
(1r,4s,5s,11r,14s,15s)-15-hydroxy-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate
16-(2,4-dihydroxy-6-methylbenzoyl)-4,6,10-trihydroxy-12-methyl-14-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12-heptaene-8,15-dione
(1r,2r,14s,15r)-4,24-dimethoxy-8,15-dimethyl-9,13,16,20-tetraoxaheptacyclo[13.11.0.0²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁷,²⁵.0¹⁹,²³]hexacosa-3(12),4,7,10,17(25),18,21,23-octaene-6,26-dione
5-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl acetate
(1s,3s,7s,8s,9r,10s,17r,18s,19s,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid
(5-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl)methyl acetate
(2e,5r)-6,6,6-trichloro-3-methoxy-n,5-dimethyl-n-[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-[(5-hydroxy-6-methoxy-4-oxo-2-phenylchromen-7-yl)oxy]oxane-2-carboxylic acid
methyl 3-{[3-methoxy-2-(3-methyl-2,5-dioxopyrrolidin-1-yl)-3-oxopropyl]disulfanyl}-2-(3-methyl-2,5-dioxopyrrolidin-1-yl)propanoate
C18H24N2O8S2 (460.09740239999996)